Related by context. All words. (Click for frequent words.) 75 Hypotension 74 hematologic toxicity 73 bone marrow suppression 73 Angioedema 73 Febrile neutropenia 72 severe hypersensitivity reactions 71 acute GvHD 71 hematologic adverse 71 nephrotoxicity 71 cytopenias 71 hematological toxicity 71 haematologic 71 Thrombocytopenia 70 alpha interferons 70 hemoptysis 70 neutropaenia 70 Malignant Glioma 70 thromboembolic events 70 leucopenia 70 Candida infection 70 Dasatinib 70 invasive candidiasis 70 thrombotic complications 70 gastrointestinal toxicity 70 β blockers 70 Hematologic 70 ALT flares 70 transaminase elevations 70 peripheral sensory neuropathy 70 myopathy rhabdomyolysis 70 Serious adverse reactions 70 Fludarabine 70 hepatotoxicity 70 pheochromocytoma 69 ALT elevations 69 gastrointestinal toxicities 69 anterior uveitis 69 Retreatment 69 Myelosuppression 69 Squamous Cell Carcinoma 69 torsade de pointes 69 B Cell Lymphoma 69 neutropenia dehydration dyspnea 69 induce orthostatic hypotension 69 Platinol ® 69 corticosteroid therapy 69 hypomagnesemia 69 Myelofibrosis 69 CYP #A# 69 thrombocytopenia neutropenia 69 relapsed MM 69 basal cell carcinoma BCC 69 dermatologic reactions 69 thromboembolic complications 69 Neutropenia 69 QTc prolongation 69 anemia neutropenia 69 leiomyomas 69 Nilotinib 69 EXJADE 69 hypercalcemia 69 hypophosphatemia 69 Decitabine 68 pancytopenia 68 Patients Receiving 68 Thrombotic 68 benign prostatic hypertrophy BPH 68 renal toxicity 68 Neulasta ® 68 candidemia 68 Paraplatin ® 68 leukemia AML 68 hemorrhagic cystitis 68 Pemetrexed 68 Anthracycline 68 thalidomide Thalomid 68 metastatic malignant 68 myelofibrosis polycythemia vera 68 TMP SMX 68 Mucositis 68 Adverse events 68 non metastatic osteosarcoma 68 proctitis 68 neutropenia thrombocytopenia 68 tumor lysis syndrome 68 headache abdominal pain 68 Fluorouracil 68 hematological toxicities 68 lichen planus 68 Leukemias 68 hypercholesterolaemia 68 cervical lymph nodes 68 Hepatotoxicity 68 pharmacokinetic interactions 68 complement inhibitor eculizumab 68 nimodipine 68 FluCAM arm 68 bacteriuria 68 perioperatively 68 FASLODEX 68 Nebulized 68 hepatorenal syndrome 68 superficial bladder cancer 68 fatal anaphylactic 68 erlotinib Tarceva ® 68 papillary renal cell carcinoma 68 Exacerbation 68 Peginterferon Alfa 2a 68 myeloproliferative diseases 68 GISTs 68 salmeterol fluticasone 68 gastrointestinal perforation 68 Eculizumab 68 CYT# potent vascular disrupting 68 allograft rejection 68 artery stenosis 68 adrenal insufficiency 68 hyperammonemia 68 Hypersensitivity reactions 68 rFVIIa 67 conventional DMARDs 67 severe neutropenia 67 cidofovir 67 radiotherapy RT 67 Mitoxantrone 67 anaphylactoid reactions 67 lenalidomide dexamethasone 67 solar keratoses 67 HIV HCV coinfected 67 hemorrhagic complications 67 proliferative diabetic retinopathy 67 Soft Tissue Sarcoma 67 haematological toxicity 67 abacavir Ziagen 67 denileukin diftitox 67 ara C 67 hyperprolactinemia 67 invasive aspergillosis 67 cardiac toxicity 67 hyperkalemia 67 Refractory Hodgkin Lymphoma 67 HeFH 67 Diffuse Large B 67 Patients Treated With 67 Pharmacokinetics PK 67 cerebral vasospasm 67 endometrial hyperplasia 67 Demonstrates Efficacy 67 cutaneous squamous cell carcinoma 67 osteosarcomas 67 Pegylated Interferon 67 adriamycin 67 Myelodysplastic Syndrome MDS 67 severe oral mucositis 67 receiving XGEVA 67 endophthalmitis 67 Chronic Prostatitis 67 INCB# [003] 67 nephrotoxic 67 cholecystitis 67 zonisamide SR 67 metastatic malignant melanoma 67 malignant ascites 67 Hormone Refractory Prostate Cancer 67 invasive fungal infection 67 mitomycin C 67 hypocalcaemia 67 metformin accumulation 67 thrombocytosis 67 febrile neutropenia 67 Allergic Rhinitis 67 metastatic neuroendocrine tumors 67 Ileus 67 APTIVUS r 67 intravenous bisphosphonates 67 myelosuppression 67 pentoxifylline 67 recurrent DVT 67 Relapsing Remitting Multiple Sclerosis 67 docetaxel Taxotere ® 67 squamous cell carcinoma SCC 67 ß blockers 67 BARACLUDE ® 67 Meets Primary Endpoint 67 Unfractionated Heparin 67 uric acid lowering 67 Malignant Melanoma 67 Antitumor Activity 67 hypercalciuria 67 tigecycline 67 Candida infections 67 urothelial carcinoma 67 acute gout flares 67 Cardiotoxicity 67 gastric adenocarcinoma 67 alfa 2a 67 epithelial tumors 67 PAOD 67 chlorambucil 67 Patency 67 fluorouracil leucovorin 67 Ischemic 67 Recurrences 67 extrapyramidal symptoms 66 CP CPPS 66 SPRYCEL ® 66 Malignancies 66 Ribavirin causes 66 Aliskiren 66 Gleevec resistant 66 Capecitabine 66 bullous 66 follicular lymphoma FL 66 cisplatin chemotherapy 66 antiandrogen 66 herpes zoster shingles 66 Eltrombopag 66 sotalol 66 Epratuzumab 66 myelodysplastic myeloproliferative diseases 66 Cytotoxic 66 Metastases 66 bezafibrate 66 noninfectious uveitis 66 Radiofrequency Ablation RFA 66 mapatumumab 66 AA Amyloidosis 66 paragangliomas 66 Cutaneous T 66 angioneurotic edema 66 Bortezomib 66 Chronic HCV 66 INVEGA ® 66 immunocompetent patients 66 DOXIL 66 Orally administered 66 immunosuppressives 66 aspartate aminotransferase 66 myalgias 66 dysplastic lesions 66 antiemetics 66 hypocalcemia 66 octreotide LAR 66 sulfasalazine 66 Peginterferon 66 rizatriptan 66 recurrent glioblastoma multiforme 66 liposomal amphotericin B 66 CLL SLL 66 caspofungin 66 systemic hypotension 66 refractory NSCLC 66 hyperbilirubinemia 66 leukoencephalopathy 66 pericardial effusions 66 hepatic toxicity 66 Glucocorticoids 66 idiopathic thrombocytopenic purpura ITP 66 lactic acidosis 66 isoproterenol 66 immune thrombocytopenic purpura 66 relapsing multiple sclerosis 66 Darinaparsin 66 dasatinib Sprycel ® 66 oral Hycamtin 66 grade cervical intraepithelial 66 Exacerbations 66 posterior uveitis 66 unresectable HCC 66 ACE Inhibitors 66 idarubicin 66 intracranial hemorrhage ICH 66 Gliomas 66 dexamethasone Decadron 66 riociguat 66 mycophenolate mofetil 66 Castration Resistant Prostate Cancer 66 DLTs 66 anthracycline chemotherapy 66 tardive dyskinesia TD 66 hyperalgesia 66 Erlotinib 66 FOLPI 66 vWF 66 reflux symptoms 66 beclomethasone dipropionate 66 piperacillin tazobactam 66 Irinotecan 66 stage IIIB 66 Corticosteroids 66 antineoplastic 66 Acute Bacterial Sinusitis ABS 66 colorectal liver metastases 66 Vidaza azacitidine 66 Hematologic toxicity 66 Infusion Reactions Severe 66 cell lymphoma CTCL 66 mitochondrial toxicity 66 Known hypersensitivity 66 PEGylated interferon beta 1a 66 chronic urticaria 66 Cimzia TM 66 Venous thromboembolism 66 Metastatic Prostate Cancer 66 Chronic Sinusitis 66 hematologic abnormalities 66 prednisone prednisolone 66 dose limiting toxicities 66 Erythropoietic therapies may 66 idiopathic thrombocytopenic purpura 66 bisoprolol 66 venous stasis ulcers 66 moderate renal impairment 66 Interferon Beta 66 receptor tyrosine kinase inhibitor 66 cisplatin carboplatin 66 alkylating agent 66 ARCALYST ® 66 4mg/kg 66 Parnate 66 toxicities 66 tumor xenograft models 66 VP# [004] 66 R Saizen R 66 AST ALT 66 systemic corticosteroid 66 MALT lymphoma 66 Hepatocellular Carcinoma HCC 66 adalimumab Humira 66 #mg/m# [001] 66 TEAEs 66 NSAID induced 66 Hyperkalemia 66 prostate carcinoma 66 bleomycin 66 primidone 66 antiarrhythmic drugs 66 dual endothelin receptor antagonist 66 pancreatic insufficiency 66 sitaxsentan 66 dermatologic toxicities 66 lymphadenopathy 66 hematopoietic cancers 66 imatinib Gleevec ® 66 potentially hepatotoxic 66 adrenal suppression 66 mucinous 65 relapsed ovarian cancer 65 Lamotrigine 65 neutropenia febrile neutropenia 65 5-FU/LV 65 Tolvaptan 65 Tolerability 65 mcg BID 65 biologic DMARD 65 labetalol 65 platelet inhibitor 65 mycophenolate mofetil MMF 65 Adjuvant chemotherapy 65 MDS MPD 65 potassium binder 65 Golimumab 65 TNF antagonist 65 MULTAQ 65 subependymal giant cell 65 Asymptomatic 65 Adefovir 65 Oral corticosteroids 65 sclerosing 65 Natalizumab 65 rash urticaria 65 headache nausea diarrhea 65 chills fever headache 65 teriflunomide 65 visilizumab 65 CIMZIA ™ 65 Chronic Myeloid Leukemia 65 interleukin IL -# 65 limiting toxicity 65 T2DM 65 mycosis fungoides 65 ACTEMRA TM 65 erythema nodosum 65 intravitreal injections 65 baseline LDH 65 Peripheral edema 65 thrombophlebitis 65 KETEK 65 intraepithelial neoplasia 65 cranial irradiation 65 recurrent genital herpes 65 Papillary 65 HBeAg negative 65 systemic toxicity 65 plasma pharmacokinetics 65 delayed CINV 65 deep venous thromboses 65 CTAP# Capsules 65 mucosal inflammation 65 Adenomas 65 intravascular hemolysis 65 VAPRISOL 65 INTEGRILIN R 65 malignant neoplasms 65 overactive bladder syndrome 65 Fungal Infections 65 LHRH agonists 65 hyperphenylalaninemia HPA due 65 antithrombotics 65 estramustine 65 pyridostigmine 65 macrovascular events 65 recurrent venous thromboembolism 65 Paliperidone 65 ischemic complications 65 immunomodulatory therapy 65 secondary hyperparathyroidism 65 FUSILEV enhances 65 suppurative 65 doxorubicin HCl 65 oral candidiasis 65 refractory gout 65 ertapenem 65 peritumoral brain edema 65 aminotransferases 65 pyrazinamide 65 nicardipine 65 Tacrolimus 65 Sjögren syndrome 65 posaconazole 65 Critical Limb Ischemia CLI 65 superficial basal cell carcinoma 65 macrolide antibiotic 65 tacrolimus ointment 65 micafungin 65 Tumor Necrosis Factor 65 coagulopathy 65 ximelagatran 65 neoplasias 65 Mitomycin C 65 cisplatin gemcitabine 65 included exfoliative dermatitis 65 surgical prophylaxis 65 colorectal adenoma 65 MGd 65 Carcinomas 65 piroxicam 65 anemia thrombocytopenia 65 bacterial prostatitis 65 chronic idiopathic thrombocytopenic purpura 65 acute leukemias 65 Navelbine ® 65 hematological adverse 65 Carboplatin 65 contrast induced nephropathy 65 Prostatic 65 Follicular Lymphoma 65 Phase 2b Trial 65 lymphoma subtypes 65 ovarian carcinoma 65 Squamous 65 Patients Treated 65 pulmonary hypertension PH 65 chemotherapy induced neutropenia 65 metastatic GIST 65 methicillin susceptible Staphylococcus aureus 65 skeletal metastases 65 CHOP chemotherapy 65 Hemophilia B 65 investigational monoclonal antibody 65 Pediatric Patients 65 Kinoid 65 lipid lowering agents 65 Teriflunomide 65 metastatic renal cell carcinoma 65 mitoxantrone plus 65 QT interval prolongation 65 thromboses 65 pharmacodynamic parameters 65 Basal Cell 65 aminotransferase levels 65 limiting toxicity DLT 65 Prolongs Survival 65 Newly Diagnosed Multiple Myeloma 65 post herpetic neuralgia PHN 65 saline placebo 65 mixed hyperlipidemia 65 fatigue diarrhea nausea 65 Hypertrophic 65 Pioglitazone 65 Cervical Dystonia 65 CIMZIA TM 65 atypical hemolytic uremic syndrome 65 either acutely decompensated 65 basiliximab 65 candidiasis 65 Investigational Treatment 65 demonstrated antitumor activity 65 corticosteroid dexamethasone 65 epistaxis 65 Doxorubicin 65 galiximab 65 cheilitis 65 somatostatin analogs 65 atrophic gastritis 65 PegIFN RBV 65 hepatic dysfunction 65 Glioblastoma Multiforme 65 non hematological toxicities 65 infusional 65 administered concomitantly 65 ribavirin therapy 65 NAGS deficiency 65 endometrial carcinoma 65 PREZISTA r 65 rituximab Rituxan 65 Sudhir Agrawal D.Phil 65 external genital lesions 65 Zollinger Ellison Syndrome 65 carboplatin paclitaxel 65 arterial thromboembolic events 65 Adjunctive 65 T1c 65 Renal impairment 65 severe exacerbations 65 EGFRIs 65 choroidal neovascularization 65 doxorubicin docetaxel 65 flutamide 65 dysmotility 65 Myelodysplastic Syndrome 65 hyperoxaluria 65 FOLFOX6 65 polidocanol 65 cytotoxic chemotherapy 65 ritonavir boosted 65 Antiviral Activity 65 NMDA antagonists 65 Sezary syndrome 65 NMIBC 65 Complicated Skin 65 Mg Uk 65 immune thrombocytopenic purpura ITP 65 Stomatitis 65 Bisphosphonate 65 oral prodrug 65 interstitial pneumonia 65 ALA PDT 65 events TEAEs 65 neurological manifestations 65 Omacetaxine 65 hepatic cirrhosis 65 neutropenic patients 65 Non inferiority 65 cytoreduction 65 mg/m2 dose 65 elevated ALT 65 lymphoproliferative disorders 65 Chronic Renal Failure 64 rebleeding 64 CANCIDAS 64 pegylated liposomal doxorubicin 64 chemoradiotherapy 64 Tiotropium 64 hepatic insufficiency 64 hemodilution 64 Renal Cell Carcinoma 64 dacarbazine DTIC 64 venous thromboembolic events 64 Sulfonylurea 64 thyrotoxicosis 64 primary immunodeficiency PI 64 dopaminergic therapy 64 Fulvestrant 64 histologic subtype 64 angioedema 64 COPD exacerbations 64 Advanced Melanoma 64 cough dyspnea 64 HPA axis suppression 64 BPH benign prostatic 64 Shows Efficacy 64 Aclidinium 64 ® lenalidomide 64 doxorubicin cyclophosphamide 64 Naive Patients 64 dysmenorrhoea 64 Relapsed Refractory Multiple Myeloma 64 Antiangiogenic 64 DMARDS 64 novel VDA molecule 64 moderate hepatic impairment 64 cholelithiasis 64 Actinic Keratosis 64 lymphopenia 64 steroid refractory ulcerative 64 gastrointestinal ulcers 64 diarrhea nausea vomiting 64 L PPDS 64 Helicobacter pylori eradication 64 nerve toxicity neurotoxicity 64 efalizumab 64 acarbose 64 ileus 64 xanthine oxidase inhibitor 64 Tumor Response 64 Hepatic Impairment 64 Improves Outcomes 64 Oral Fingolimod 64 CYP#A# substrate 64 Pegylated Liposomal Doxorubicin 64 atrial tachyarrhythmias 64 Intravitreal 64 docetaxel chemotherapy 64 oral thrush 64 Intravenous immunoglobulin 64 Metastatic breast cancer 64 R lenalidomide 64 deferiprone 64 voriconazole 64 sensory neuropathy 64 cytopenia 64 diabetic peripheral neuropathy DPN 64 dysplasias 64 Daptomycin 64 aspartate aminotransferase AST 64 Safinamide 64 alfuzosin 64 Dose limiting toxicities 64 ISTODAX 64 diabetic gastroparesis 64 Bezielle 64 doxorubicin Adriamycin 64 alefacept 64 SSc 64 Metastatic Colorectal Cancer 64 fatigue asthenia 64 overlapping toxicities 64 prokinetic agent 64 diabetic kidney 64 neuroendocrine cancers 64 lenalidomide Revlimid R 64 erythropoietic 64 vinorelbine 64 Single Dose 64 CK # administered 64 perioperative complications 64 antimuscarinic 64 paroxysmal AF 64 Atypical antipsychotics 64 5 Fluorouracil 64 FOLFIRI 64 Carcinoma 64 fluvastatin 64 platinum refractory 64 Carcinoid tumors 64 Prophylactic Treatment 64 injected subcutaneously 64 TNF Tumor Necrosis Factor 64 grade glioma 64 pyrexia mucositis sepsis febrile 64 variceal hemorrhage 64 TAXOTERE ® 64 alpha 2a 64 cutaneous lupus 64 Host Disease GvHD 64 myalgia arthralgia 64 evaluating tivozanib 64 PR interval prolongation 64 renal insufficiency 64 recurrent glioma 64 bronchial hyperresponsiveness 64 Diabetic Neuropathy 64 mucocutaneous reactions 64 serologically active systemic lupus 64 milrinone 64 hepatocellular 64 Pulmonary embolism 64 gastrointestinal stromal tumor 64 HCV Genotype 64 Telithromycin 64 BENICAR HCT 64 eosinophilic asthma 64 histological subtype 64 antiplatelet medications 64 Elderly Patients 64 LHRH analogues 64 platelet dysfunction 64 urothelial cancer 64 endothelin receptor antagonists 64 SCCHN 64 Bevacizumab 64 carcinoid tumors 64 ribavirin RBV 64 hepatic encephalopathy HE 64 hypoglycemic events 64 Abrupt discontinuation 64 coadministration 64 cilengitide 64 nausea vomiting headache 64 See CLINICAL PHARMACOLOGY 64 hypertrophic scars 64 Demonstrates Positive 64 Carbamazepine 64 esophagitis 64 leukopenia 64 thrombotic events 64 MAGE A3 ASCI 64 receiving highly emetogenic 64 Anaplastic 64 mitomycin 64 primary hyperparathyroidism 64 Relapsing Multiple Sclerosis 64 imatinib resistance 64 oesophagitis 64 amphotericin B 64 serum urate levels 64 thromboembolic 64 Phase 2b Clinical Trial 64 Itraconazole 64 Radiofrequency ablation 64 trimethoprim sulfamethoxazole 64 Hurthle cell 64 imatinib resistant 64 post surgical adhesions 64 primary Restless Legs 64 Tigecycline 64 thromboembolism 64 INFERGEN 64 variceal bleeding 64 paresthesias 64 locoregional recurrence 64 CTEPH 64 idiopathic PAH 64 hepatic enzymes 64 bortezomib Velcade 64 pseudomembranous colitis 64 PEG IFN 64 neutrophil counts 64 thromboembolic disease 64 nephrotoxic drugs 64 paclitaxel carboplatin 64 Vicinium TM 64 pan HDAC inhibitor 64 Alequel 64 zolmitriptan 64 ergotamine 64 idraparinux 64 adrenocortical cancer 64 abacavir lamivudine 64 cardiotoxicity 64 Atypical Hemolytic Uremic Syndrome 64 Risedronate 64 Noxafil 64 generalized seizures 64 morphometric vertebral fractures 64 receiving VICTRELIS 64 pyelonephritis 64 nonmelanoma skin cancers 64 antiphospholipid syndrome 64 Amrubicin 64 vWD 64 TMC# r 64 vesicoureteral reflux 64 Neovascular Age Related Macular 64 Epidermal Growth Factor Receptor 64 ZYVOX 64 Imiquimod 64 receiving VELCADE 64 capillary leak 64 erythematosus 64 TELINTRA 64 infliximab Remicade 64 chronic immune thrombocytopenic 64 FOLFIRI alone 64 interferon alfa 2b 64 Antiviral Therapy 64 Enzastaurin 64 azacytidine 64 hematologic parameters 64 elevated transaminases 64 oral levofloxacin 64 Fondaparinux 64 eosinophilic pneumonia 64 Infusion reactions 64 pulmonary dysfunction 64 prostate cancer CaP 64 Anticholinergic 64 comparator arm 64 elevated plasma concentrations 64 postoperative morbidity 64 sorafenib Nexavar 64 hypersensitivity reactions 64 renal scarring 64 baminercept 64 Progressive Multifocal Leukoencephalopathy 64 GnRH agonist 64 Pazopanib 64 Pharmacodynamics 64 leukemia ALL 64 tumor necrosis 64 haloperidol Haldol 64 concomitant medications 64 Tyrosine Kinase Inhibitors 64 Pulmonary Arterial Hypertension PAH 64 Moxifloxacin 64 digoxin toxicity 64 Nocturia 64 gemcitabine carboplatin 64 xenograft tumors 64 CIN3 64 lysosomal storage disease 64 colorectal carcinoma 64 vasospasm 64 NSAID induced GI 64 MCyR 64 antithrombotic therapy 64 oxycodone CR 64 Protease Inhibitors 64 malabsorptive 64 VIIBRYD 64 intracranial hypertension 64 BAL# [002] 64 reactogenicity 64 Immunotherapeutic 64 anemia hemoglobin 64 8mg/kg 64 tryptase 64 Non Alcoholic Fatty 64 leukotriene receptor antagonist 64 ISTODAX ® 64 heparin induced thrombocytopenia 64 bovine thrombin 64 pegylated interferons 64 polycythemia vera essential thrombocythemia 64 severe renal impairment 64 grade gliomas 64 docetaxel Taxotere R 64 administered subcutaneously 64 Acute myeloid leukemia 64 COPD exacerbation 64 atherothrombotic 64 metastatic colorectal 64 tachyarrhythmias 64 Juvenile Idiopathic Arthritis 64 familial amyloidotic polyneuropathy FAP 64 Thromboembolic 64 pimecrolimus cream 64 chloride secretion 64 HoFH 64 Meningiomas 64 Immunomodulatory 64 mu opioid receptor antagonist 64 gemcitabine Gemzar 64 intravesical therapy 64 immunosuppressive regimen 64 Pivotal Phase III 63 symptomatic intracranial hemorrhage 63 Hemolysis 63 Monotherapy 63 leukopenia pancytopenia thrombocytopenia 63 indolent NHL 63 anthracyclines taxanes 63 Fingolimod 63 ADPKD 63 KRAS mutant tumors 63 Mg Usa 63 urticaria hives 63 Cyclophosphamide 63 syncope fainting 63 Rheumatoid Arthritis Patients 63 testicular tumors 63 Pegylated 63 Well Tolerated 63 oral vancomycin 63 surgically resectable 63 Previously Treated 63 Adjuvant Chemotherapy 63 Methylnaltrexone 63 divalproex sodium 63 Bronchiectasis 63 chemoradiation therapy 63 myelodysplastic syndrome MDS 63 Hepatic Encephalopathy 63 mTOR inhibitors 63 hepatocellular carcinomas 63 Intravitreal injections 63 anogenital warts 63 fibrinolytic 63 hypereosinophilic syndrome 63 anticholinergic agents 63 recurrent malignant glioma 63 Hsp# Inhibitor 63 Liver Injury 63 INVEGA ™ 63 primary aldosteronism 63 antiangiogenic therapy 63 advanced hepatocellular carcinoma 63 transdermal estradiol 63 parasitemia 63 tuberous sclerosis TS 63 PCNSL 63 Cell Lymphoma CTCL 63 IV bisphosphonates 63 Tasigna nilotinib 63 pouchitis 63 Pulmonary hypertension 63 S. aureus bloodstream infections 63 dalteparin 63 inflammatory acne 63 Navelbine 63 gemifloxacin 63 postsurgical pain 63 hyperparathyroidism 63 chronic myeloid 63 chronic eosinophilic leukemia 63 DFMO 63 neurologic symptoms 63 neurologic deficits 63 Subarachnoid hemorrhage 63 velafermin 63 pentamidine 63 antiepileptics 63 hypersensitivity reaction 63 Unstable angina 63 liposomal doxorubicin 63 mitoxantrone chemotherapy 63 clevidipine 63 Lymphoid 63 NYHA Class II 63 Neoplasms 63 VA# [002] 63 serum cortisol 63 melphalan prednisone 63 Fluid retention 63 #mg BID [001] 63 aprepitant 63 prolonged QT interval 63 homozygous familial hypercholesterolemia 63 nasopharyngitis headache 63 selective modulator 63 pericardial effusion 63 meropenem 63 malignant lymphomas 63 elevated triglyceride levels 63 dyskinesia PD LID 63 metastatic bone 63 busulfan 63 HBeAg positive 63 postoperative nausea 63 Linezolid 63 cardiotoxic 63 glomerular filtration 63 Efficacy Trial 63 PKC# 63 eosinophilia 63 dasatinib Sprycel 63 Hypercholesterolemia 63 nonhematologic adverse reactions 63 Posaconazole 63 polyarticular 63 lymphocytosis 63 Phase 2a Clinical Trial 63 GP IIb IIIa inhibitors 63 ergot alkaloids 63 Embolization 63 AZT zidovudine Retrovir 63 Trastuzumab 63 symptomatic paroxysmal AF 63 Cytarabine 63 Diabetic Macular Edema 63 Androgen Deprivation Therapy 63 inhibitor RG# 63 Nonspecific 63 transarterial chemoembolization 63 constipation nausea 63 imatinib Gleevec 63 acitretin 63 soft tissue sarcomas 63 malignancy HCM 63 cutaneous melanoma 63 INVANZ 63 vasodilators 63 colorectal adenocarcinoma 63 esophagogastric 63 CrCl 63 zoledronate 63 metastatic RCC 63 Anti VEGF 63 IV NSCLC 63 chronic GVHD 63 Endometrial 63 NATRECOR ® 63 Peginterferon alfa 2b 63 Hemangiomas 63 EGFR HER2 63 dosed orally 63 Non Alcoholic Steatohepatitis 63 trastuzumab Herceptin ®